Skip to content

Scleroligation for Eradication of Gastroesophageal Varices.

Scleroligation is a Safe and Effective New Technique for Eradication of Gastroesophageal Varices.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02646202
Enrollment
90
Registered
2016-01-05
Start date
2015-01-31
Completion date
2021-12-31
Last updated
2017-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Varices

Brief summary

Gastric varices occur in 5-33% of patients with portal hypertension. Concomitant gastro esophageal varices are the most common type. Both endoscopic sclerotherapy and band ligation are very effective in controlling acute esophageal varices bleeding and preventing rebleeding.

Detailed description

Evaluation of a new scleroligation technique for management of bleeding gastro-esophageal varices regarding efficacy, complications, variceal recurrence, and survival.

Interventions

PROCEDUREBand ligation

endoscopic banding of varices

PROCEDURESclerotherapy

Injection of varices

PROCEDUREScleroligation

intra variceal endoscopic sclerotherapy combined with band ligation.

Sponsors

Tanta University
CollaboratorOTHER
Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* cirrhotic patients presenting with an acute or recent episode of gastro-esophageal variceal bleeding.

Exclusion criteria

* Patients were excluded if they had malignancy of any origin. * Any terminal illness, such as heart failure, uremia, or chronic pulmonary diseases. * Other potential causes of GIT bleeding. * Patients with previous endoscopic or surgical intervention for varices were also excluded.

Design outcomes

Primary

MeasureTime frame
Number of sessions to complete variceal obliteration1 year

Countries

Egypt

Contacts

Primary ContactSherief M. Abd-Elsalam, Consultant
sherif_tropical@yahoo.com00201095159522

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026